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Chapter 1
Introduction
1.1 Introduction
We have had major advancements in genetic studies since the first nearly complete sequence
of the human genome in 2003[26]. Genotyping millions of genetic variants and directly test-
ing associations between phenotypes and single nucleotide mutations has become a common
practice. These genome-wide association studies help to lay the foundation for further research
by finding associations between genes and diseases. These associations in turn have been a
significant tool in studying complex diseases that are affected by multiple genes, lifestyle and
environmental factors. For example, statins have been commonly applied for preventing and
managing cardiovascular disease and genetic studies identified that the gene HMGCR can be
used as a marker for statin efficiency[30].
The data used in this thesis are from European Multicenter Study on Familial Dyslipidemias
in Patients with Premature Coronary Heart Disease (EUFAM) study. The EUFAM study aims
to analyze metabolism and genetic abnormalities of familial dyslipidemias predisposing to coro-
nary heart disease (CHD). A strong motivation for the study is that the coronary heart disease
is one of the leading causes of death worldwide[18]. The metabolic traits are highly heritable.
Therefore, studying the genetic contribution is important for both prevention and treatment
of the diseases. For instance, in healthy young adults different high-density lipoprotein traits
were generally over 50% heritable[39].
Family data are used in the EUFAM project as the families might have genetic characteristics
that increase the susceptibility for the CHD. These characteristics can be harder to find when
a population sample is used. Family data pose some challenges. The largest one being the
data collection: collecting family data usually requires more time and effort than collecting
a population sample. The dependence between the individuals also needs to be taken into
account using methods such as the linear mixed model.[33]
In the first chapter the thesis presents the background for understanding the analyses. At
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the beginning some general genetic concepts are introduced, such as the human genome and
inheritance. We will then look at the definition and usage of heritability. After this single-
nucleotide polymorphism and genome-wide association studies are examined. The chapter ends
with a review on benefits that Finland offers in these kinds of studies.
The EUFAM data are presented in chapter 2. The subjects and both genotyping and
imputing the SNPs will be examined in this chapter. The phenotypes included in the analyses
are also listed here.
In chapter 3 we will see why the linear mixed model is needed and how it works. We will
look at applying the model for the EUFAM data and take a glance at previous studies that use
LMMs. Finally, the statistical testing methods are discussed.
The results chapter is divided into two sections. The simulations will be examined to show
the model performs correctly before moving on to the results with EUFAM data. The results
for the EUFAM data are discussed only briefly as they will be published later on.
A list of abbreviations can be found at the end of the thesis.
The program Genome-wide Complex Trait Analysis (GCTA)[53] is used to estimate the
heritability of the phenotypes and MMM[40] is used to perform the genome-wide association
study (GWAS). Both of these are freely available from their respective web sites.
The aims of this Master’s thesis:
1. Explain what a linear mixed model (LMM) is and when it is needed. In short, the LMM
is a combination of linear fixed and random effects models and it takes the clustering of
the data (such as a family structure) into account.
2. Evaluate how available implementations of LMMs work on real family structures. The
evaluation includes estimation of the variance components, association testing and type
I/II errors.
3. Apply the model to real data from the EUFAM project. The results are only briefly
discussed in the thesis as the results will be presented in upcoming articles.
1.2 Genetic material
The genome stores genetic instructions which affect the observable or measurable parts of
the organism, such as eye color or high-density lipoprotein (HDL). The genome consists of
deoxyribonucleic acid (DNA) and the order of the four bases in the DNA, adenine (A), cytosine
(C), guanine (G), and thymine (T), determines what the sequence in the genome encodes.[44]
The human genome is a linear sequence of 3 × 109 bases, which is cut out unevenly into
23 pairs of chromosomes, that is, the packed form of DNA. The sequence has around 20,000
5
Figure 1.1: An illustration of inheritance of different alleles and HDL level (mmol/L) in a
family. In this example the green allele might have a decreasing effect on the HDL level that
the individual has.
sections of which code for a protein, that is genes. The whole genome does not code for proteins,
genes are separated by sections whose possible function is not well known. These non-coding
parts might still affect the phenotypes, for instance, they could change the expression of the
genes.[6][44]
The simplified version of the genome’s function is protein creation. The proteins are essential
for living organisms as they perform various life sustaining functions. They are formed out of
amino acid sequences which in turn are coded by sequences of three nucleotides in the DNA
sequence. There are 64 different three-base-combinations but only 22 distinct amino acids.[44]
An offspring inherits half of its genome from the mother and half from the father. An
example of a family with low HDL levels and inheritance of four different alleles, alternative
forms of DNA regions, genes or bases, can be seen in Figure 1.1. As HDL is affected by both
genetics and environment we cannot directly know the HDL level of an offspring by only looking
at the genome of the offspring. But by studying the genome of the individuals in combination
with the HDL levels we might find parts of the genome that are associated with lower or higher
levels of HDL. We can also estimate how much the genetics explain the variation we see in the
HDL measurements between individuals, i.e. heritability of HDL levels. In this example HDL
level is a phenotype: a measurable trait that is affected by the genetics of the individual.
1.3 Heritability
Heritability refers to the proportion of variation of a trait that can be explained by genetics[48].
Let us first take a look at the formulation of heritability and then examine more thoroughly
the meaning of it.
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1.3.1 Definition
We can divide the variance of a phenotype, VP , into two parts[44]:
VP = VG + VE
where VG refers to genetic variance and VE refers to variance caused by the environment. We
assume that there is no interaction between the genetics and the environment, that is, there is
no VG×E term.
The genetic variance can be further broken down into additive genetic effects (VA), dom-
inance effects (VD), and interaction variance (VI). The dominance effects refer to how some
alleles may be dominant and some recessive so the effect of genotype is not the sum of the
effects of the alleles. The interaction variance takes into account the variance caused by alleles
from different segments of DNA, in other words alleles from different loci, interacting with each
other. Using these term the genetic variance is:
VG = VA + VD + VI .
With this notation we can define two types of heritabilities, broad-sense and narrow-sense
heritability. The broad-sense heritability, H2 is obtained by scaling the genetic variance with
all the variance in the phenotype, that is[44]:
H2 =
VG
VP
The narrow-sense heritability, h2, is obtained similarly but instead of dividing the genetic
variance we divide the additive variance[44]:
h2 =
VA
VP
. (1.1)
The narrow-sense heritability is a more popular measurement as the dominance and inter-
action variances can be hard to measure. The narrow-sense heritability is used in this thesis.
1.3.2 Usage and estimation
Heritability can be used to make predictions of the effect of selection, both natural and artificial.
Heritability allows comparisons between the same phenotypes across populations and different
phenotypes within population. These comparisons can help to understand the biology behind
a trait. Heritability is also important for association studies as high heritability means that
loci affecting the trait are easier to find.
It can also determine how efficiently we can predict an individual’s genetic risk for a disease
or condition. However, high heritability does not mean the genotype completely predicts the
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phenotype because the environment still affects the phenotype. Also high heritability does not
tell us anything about the effect sizes or the number of the genes affecting the trait.[48]
Heritability can be estimated with regression using parent-offspring samples, calculating
correlation in full or half siblings or by calculating the difference in the correlation between
monozygotic and dizygotic twin pairs. Heritability can also be estimated using linear mixed
model with family data containing a mixture of relationships. Even data without clear family
structure can be used, such as population data, as we can calculate the relatedness of the
individuals from the genomic data.[48]
1.4 Single nucleotide polymorphism
1.4.1 What is a SNP?
Table 1.1: Examples of SNPs in this thesis.
Reference sequence AACTA
Point mutation
AAGTA
C − > G
Insertion
AACCTA
- − > C
Deletion
AA-TA
C − > -
There are various kinds of changes, that is
mutations, that can occur in the nucleotide
sequence. These changes can happen, for ex-
ample, because of errors in the copying pro-
cess of the DNA, radiation or chemicals.[44]
Depending on the type of the mutation
and the place in the nucleotide sequence it
occurs the mutation can alter a gene, change
its expression or stop a gene from working[44].
These changes can affect the phenotypes. For
example, a mutation might provide protection
against high levels of low-density lipoprotein
cholesterol (LDL-C).
If a nucleotide has more than one allele
with frequency over 1% in the population the variation is called a single nucleotide polymorphism
(SNP). Polymorphisms are fairly common in the human DNA as about one in 300 nucleotides
has at least two alleles that have a frequency over one percent in the population. This means
that there are around 10 million SNPs in the human genome.[44]
For the sake of clarity, in this thesis a “SNP” refers to point mutations (nucleotide changes
to another nucleotide), single-nucleotide insertions, and deletions. The three mutation types
are shown in Table 1.1.
1.4.2 Why are SNPs so widely used in studies?
Besides having direct consequences, SNPs can also be used to identify multiple polymorphisms
in a region of DNA. This is caused by linkage disequilibrium: particular combinations of alleles
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Figure 1.2: An illustration of tag SNPs. In the top panel, each line represents a section of DNA
with three different SNPs. In the middle panel the DNA section has been compressed into only
SNPs. In the bottom panel the haplotype section has been further compressed into only a few
SNPs that are enough to determine which haplotype the individual has.
in regions that are nearby in the DNA tend to be inherited together. The regions that are
inherited as a block are called haplotypes. In association studies this allows us to identify
multiple polymorphisms on a short block of DNA just by genotyping a few of them. This has
lead to the usage of tag SNPs which are illustrated in Figure 1.2.[44]
There is also the HapMap (Haplotype Map) project[46] which aims to map the haplotypes
in the human genome across different populations. The HapMap project is vital for the genome-
wide association studies as it can be used to design genotyping chips to measure the tag SNPs
for the population that will be sampled. This significantly reduces the amount of SNPs needed
to be genotyped to capture a large part of the differences in the DNA. Currently, genotyping
chips can measure a million SNPs with the cost of around one hundred euros per sample.
To summarize, SNPs are widely used in genetic studies because of the cheap genotyping
cost, abundance of SNPs in the genome, and their robustness in capturing the changes in the
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genome.
There already exist some catalogs describing the human genetic variation, including SNPs,
such as the 1000 Genomes project[42].
1.5 Genome-wide association studies
1.5.1 What is a GWAS?
In a genome-wide association study (GWAS) the association of hundreds of thousands of SNPs
is tested against clinical conditions and phenotypes. For example we can test if individuals
with higher cholesterol levels have a SNP A instead of T at chromosome 1 at position 10,000
more often than what we would except them to have just by chance. As the SNP tags a region
we should also see associations in the nearby region of DNA. As mentioned previously some
regions of the DNA are usually inherited as a unit. So the individuals do not have to be closely
related as they may have a distant common ancestor from whom they have inherited the same
haplotype.
The statistical associations found are false positives or true associations. A false positive
might be a result of a false significant test result (type I error). It can also be a result of
confounding caused by population stratification, for example both the tested allele and low
levels of LDL cholesterol may be more frequent in one subgroup in the data. A true association
can be a result of the linkage disequilibrium: SNP tags a segment of the DNA, locus, which
increases susceptibility for having low/high values of the phenotype or having a disease. A true
association can also be a consequence of the SNP causing a direct result, for example a SNP
might directly increase levels of HDL.[44]
A GWAS is performed with a common disease-common variant hypothesis. The inherited
ancient haplotype blocks are assumed to have a small effect on the phenotype and the number
of loci affecting the trait is presumed to be high. These assumptions came from the fact that
the haplotypes have been able to persist through many generations of natural selection.[44]
Some populations have advantages over others when performing a GWAS. Populations that
are relatively recent and came from a small number of founders have less diversity in their
haplotypes and the haplotype blocks themselves are longer. Recent population admixtures can
also help in mapping interesting loci. Different incidences of the disease in the populations help
in mapping the regions affecting the disease.[44]
As the association testing is done genome-wide there can be millions of SNPs that will
be tested. A multiple testing correction needs to be used because the probability to get at
least one significant test result by chance (Type I error) rises with the number of tests. A
genome-wide significance threshold based on Bonferroni correction for one million independent
test is commonly used as a threshold in GWAS. The threshold is obtained by dividing the
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standard threshold of 0.05 with the number of tests: 0.05/106 = 5× 10−8[2]. There have been
studies about the threshold and many of the results have been close to this standard threshold.
For example, a simulation study using the ENCODE Project Consortium[16] gave nearly the
standard threshold (5.2× 10−8) for Europeans[23]. Another study performed simulations for a
sample of 5000 cases and 5000 controls from a European population and obtained a genome-
wide threshold of 3.1× 10−8[15].
Because the effect of a single SNP is usually small (< 1% of the phenotypes variance) and
there is a wide range of other effects on a phenotype the GWAS are mainly used as a way to
examine biological pathways for both causing diseases and normal health and development.[37]
GWAS studies have been a popular way to examine human biology. There are currently over
15 000 genome-wide significantly associated SNPs from over 2100 publications at the GWAS
catalog[21]. This catalog can be used to check replications for the associations found in new
studies.
1.5.2 Approaches
If we want to study a disease or a condition a case-control approach can be used in GWAS.
In case-control study we compare individuals who have the disease or condition we want to
study (cases) to individuals who otherwise are similar to cases but do not have the disease or
condition (controls)[4]. A large sample can be obtained as we enrich for cases, which are rare
in population. Case-control studies are good in capturing common variants but it may fail to
achieve enough power to detect variants that are rare in the population. In case-control study
we try to find SNPs that are associated with the increased or lowered odds ratio for the disease
or condition, for example we might find an allele that is associated with having 1.3 times higher
odds for having a cardiovascular disease.
We may also use quantitative phenotypic data, such as height or lipoprotein levels. In this
case we have measurements of the phenotypes and try to find SNPs that are associated with
the phenotype, e.g. an allele that is associated with having a higher LDL level.
A population sample is used for studying common variants in a population. With this
approach there exists a problem of population stratification: the subpopulations may have
different allele frequencies and it can be hard to take them into account when testing for
associations.[33]
In a family sample alleles which are rare in the general population might be enriched leading
to associations that might be missed when using a population sample. Using a family based
approach in a GWAS also provides protection against the heterogeneity of the population.
Family data also have protection against genotyping errors as genotypes can be checked against
inheritance[33]. The biggest downside of using a family based study is that the samples are
harder to obtain as families that suffer from a specific disease are needed.
The lack of a big enough sample size is a significant problem in GWAS. We may need
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thousands or even tens of thousands samples before we can detect some associations. This has
lead to the establishment of many collaborations for GWAS. For example, the wikigenes.org
website lists 112 different consortia ranging from type I diabetes to pancreatic cancer cohorts[3].
1.5.3 Missing heritability
A notable problem has arisen when comparing the estimated heritability to the effects of the
SNPs that have been associated with the trait: the variance that the SNPs explain is much
lower than the estimated heritability. This phenomenom is called the missing heritability. For
example the heritability of human height has been estimated to be around 80% but in 2010 the
variants associated with it only explained roughly 5% of the variation[52]. When considering
all the common SNPs together the variance explained by the SNPs was estimated to be 45%
which is still significantly lower than what the total heritability is estimated to be.
There are two suggested reasons to why the missing heritability problem occurs. The first
one is that the SNPs that are genotyped do not capture all the important variation in the DNA.
For instance, SNPs that are rare in the sample, say ≤ 1%, have often been dropped as they
would not have enough power to detect associations[37]. The second one is that the associa-
tion studies themselves do not detect all the causal variants because of the strict significance
thresholds.[52]
1.5.4 Imputation
Imputation is an important statistical technique to “fill in” blanks in the genomic data. We
do not need to genotype as many SNPs as we would have to otherwise as we can use the
reference panels to impute untyped SNPs. This is viable because of how some allele groups
in chromosomes are usually inherited together[44]. Imputation can be thought of as “reverse
tag SNP”: using tag SNPs we compress the information to few SNPs but with imputation we
uncompress the information to acquire more SNPs.
Figure 1.3 illustrates the imputation process. In imputation, we fill in the SNPs that we did
not genotype by comparing the SNPs we did genotype to a set of more densely genotyped indi-
viduals. The untyped genotypes are usually estimated using a hidden Markov model (HMM).
Imputation can also be used to do meta analysis on different studies whose genotype panels do
not directly match each other. This is particularly important as smaller studies may simply
not have enough power to detect SNPs that actually have a small effect.
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Figure 1.3: Illustration of the general idea behind SNP imputation. The top panel contains the
genotyped SNPs. We can compare the genotyped SNPs to a reference panel (middle panel) in
which more SNPs have been genotyped. In the bottom panel we “fill in” the spots we did not
genotype using the best matching parts from the reference panel and probabilistic models. The
DNA sequences to be imputed do not have to match directly to one individual in the reference
panel, as the sequences are usually combinations of different reference sequences. We can also
genotype a few individuals more densely in our study and use them to impute SNPs for others
especially in family based studies.
1.5.5 SNP info
In software packages like SNPTEST[29] and IMPUTE[24] the SNP info is a measurement with
a scale from 0 to 1 of how much information the imputed SNP brings when compared to the
genotype data. Info can be one if the SNPs are imputed with no uncertainty.
IMPUTE gives a probability distribution for the genotype of each imputed SNP. A marginal
probability is calculated for each of the possible alleles using a hidden Markov model.
MMM[40] extends this measurement by comparing the information obtained by using the
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population allele frequencies to the information from the individuals genotype:
info = 1− 1
n
n∑
i=1
vi
vHW
where vi is the variance of individual i’s genotype distribution given by IMPUTE and vHW is
the variance when the genotype is from the population under Hardy-Weinberg equilibrium.
In Hardy-Weinberg equilibrium we can assume that without evolutionary influences the
allele and genotype frequencies will remain constant from generation to generation. The equi-
librium does no usually hold in real populations as at least some evolutionary influences affect
the population. With single locus and two alleles, A and B, the Hardy-Weinberg equilibrium
states that using allele frequencies of f(A) = p and f(B) = q the genotypic frequencies will be
f(AA) = p2, f(AB) = 2pq, and f(BB) = q2.[44]
1.6 Benefits of using the Finnish population in genetic
studies
From geneticist’s point of view Finland offers some benefits compared to other populations
because of the population history. One notable influence on the Finnish population genetics is
the small founder population leading to founder effect [44]. Founder effect refers to the loss of
genetic variation that is caused when a new population is established by a very small number
of individuals from a larger population[44]. As mentioned previously having relative recent
founders and small number of them increases the length of the shared haplotype blocks and
decreases heterogeneity among the blocks[44].
Bottleneck effects have also had a significant impact on the Finnish population genetics.
The bottleneck effects can be observed when there is a huge reduction of the population size
which in turn reduces the genetic variation of the population lowering the genetic diversity[44].
Figure 1.4 illustrates the bottleneck effect.
There has also been a lack of internal migration causing isolates within the population[38].
The founder effect, bottleneck effects and the internal migration have all lead to the unique
genetic characteristics in the Finnish population including the so called Finnish disease her-
itage[32]. This refers to some rare diseases that are more common in the Finnish population
due to the earlier mentioned population history. The opposite has also happened, some diseases
that are common elsewhere are extremely rare in Finland.
As an example of the unique genetic characteristics, a study was recently performed to
explore if the Finnish population could be used to study low-frequency (0.5% - 5%) variants in
complex diseases[27]. In the study, the coding regions of 3,000 Finnish individuals and 3,000
non-Finnish Europeans (NFEs) were compared to study the effects of the population bottleneck.
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Figure 1.4: An illustration of the population bottleneck. We have a parent population which
meets a population bottleneck. The bottleneck is caused by a drop in the population size, for
example due to an infectious disease. Only a few individuals survive the bottleneck causing the
next generation to have less genetic variation and fewer alleles. Here the balls characterize the
genetic variation of the population. Because only the orange and green balls got through the
population bottleneck the next generation will comprise of them.
The study found out that rare and low-frequency deleterious alleles are more frequent in the
Finnish population when compared to the non-Finnish Europeans. However, the common allele
rates were the same between Finns and NFEs which suggests that while rare variants do not
usually survive a bottleneck the ones that do increase in frequency. Singleton mutations, that is
mutations that were only observed in one individual in the study, seemed to be rarer in Finland
as on average a Finn had 3.7 fewer singletons than a NFE. The results of the study can be seen
in Figure 1.5 where the allele counts and frequencies are plotted against the ratio of the number
of variants in Finns and number of variants in NFEs. The graph compares loss-of-function,
missense (mutation changes the codon of the sequence), and synonymous (mutation does not
change the codon of the sequence) mutations.
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Figure 1.5: A graph of the number of variants in Finland divided by the number of variants in
non-Finnish-Europeans (NFE) showing that loss of function mutations have enriched in Finland
when the mutation is uncommon. The “p” refers to p-values. Missense and synonymous
mutation are also enriched when the frequency is from 1% to 5%. This is the result of the
population bottleneck in Finland but the other aspects of Finnish population history also
affect the enrichment of the rare variants. The graph is from “Distribution and medical impact
of loss-of-function variants in the Finnish founder population” by Lim et al.[27]
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Chapter 2
Materials
2.1 EUFAM data
The European Multicenter Study on Familial Dyslipidemias in Patients with Premature Coro-
nary Heart Disease (EUFAM) investigates the metabolism and genetic abnormalities of familial
dyslipidemias predisposing to coronary heart disease (CHD). The study is a collaboration be-
tween Institute for Molecular Medicine Finland (FIMM), University of California at Los Angeles
(UCLA), and Washington University School of Medicine.
The EUFAM project has been supported by:
• Academy of Finland • University of Helsinki
• Finnish Heart Foundation • Emil Aaltonen’s Foundation
• International HDL Research Awards
(C.E.)
• Sigrid Juselius Foundation (M.J., M.R.T.)
• Alumni Association for Hiroshima
University Graduate School of Biomedical
Science
• Department of Molecular and Internal
Medicine (H.W.)
• National Graduate School of Clinical
Investigation (S.S.)
• Paavo Nurmi Foundation
• US National Institute of Health (NHLBI) • Laubisch Foundation
• Center of Excellence of Disease Genetics
of the Academy of Finland
• Maud Kuistila Foundation
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• Finnish Cultural Foundation • Finnish Heart Foundation
• Duodecim Foundation • Clinical Research Institute
• Helsinki University Central Hospital • Finnish Cardiovascular Research
Foundation
2.2 Subjects
The probands, the first affected family members who sought medical attention for a genetic
disorder, were identified from individuals admitted to university hospitals in Helsinki and Turku.
The probands had a diagnosis of dyslipidemia and either abnormally premature CHD (30-60
years of age and a myocardial infarction (MI)) or >50 % stenosis, an abnormal narrowing in a
blood vessel or other tubular organ or structure.
The probands were given a diagnosis based on their measured blood lipid profile using the
age- and gender-specific Finnish population percentiles from the National FINRISK Study[47].
The diagnosis criteria for Familial combined hyperlipidemia (FCHL) and low high-density lipopro-
tein cholesterol (low HDL-C) can be seen in Table 2.1. Probands were screened with a functional
LDL receptor test[7] to exclude individuals with Familial hypercholesterolemia.
Table 2.1: Criteria for the inclusion of individuals and families in the EUFAM study.
Disorder FCHL Low HDL-C
Proband lipid crite-
ria
TC and/or TG ≥ 90th percentile HDL-C ≤ 10th percentile
Proband exclusion
criteria
Diabetes mellitus, hepatic or
renal disease, hypothyroidism,
malignancies, estrogen usage or
classic familial
hypercholesterolemia
Diabetes mellitus, hepatic or
renal disease, hypothyroidism,
malignancies, estrogen usage or
classic familial
hypercholesterolemia
Further exclu-
sion criteria for
probands
- TG >2.3 mmol/l or TC >6.3
mmol/l in men and >6.0 in
women
Family criteria At least two affected (same
criteria as the proband) members
At least two affected (same
criteria as the proband) members
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Figure 2.1: An example of a family in the EUFAM data. In this family we have individuals from
three different generations in the study. FCHL refers to Familial combined hyperlipidemia.
The family members were diagnosed using the same criteria as the probands and families
with more than one affected individual were included in the study. An example of a family in
the EUFAM study can be seen in Figure 2.1.
Nearly 1600 individuals from around 150 families were genotyped and imputed. To boost
the power of the study the data also include some individuals who did not meet the requirements
for either the FCHL or low HDL-C families. Summary of the family sizes after quality control
can be seen in Figure 2.2.
The EUFAM data have been previously used in studies “Familial combined hyperlipidemia is
associated with upstream transcription factor 1 (USF1)”[34] by Pajukanta et al. 2004; “Linkage
of familial combined hyperlipidaemia to chromosome 1q21-q23”[35] by Pajukanta et al. 1998;
“Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24. 1-24.2, and
20q13. 11 in Finnish families”[43] by Soro et al. 2002. Those studies have identified strong
linkage to familial combined hyperlipidemia or low serum levels of high density lipoprotein
cholesterol at several regions. The goal of the EUFAM project is to revisit the data with
modern genotyping technologies as explained next.
2.3 Genotyping and imputing
The DNA samples were genotyped during 2013 in University of California, Los Angeles (UCLA)
using IlluminaCoreExome BeadChips (Illumina Inc, San Diego, CA, USA).
The zCall[20] software was used for calling, i.e. assigning, the genotype data: we estimate
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Figure 2.2: Barplot of the family sizes in the EUFAM data. After the quality control some
families have only one family member in the study.
a probability for each allele and assign the most probable one as the SNP that the individual
has.
The genotypes were then phased, that is we estimate from which parent the allele was inher-
ited from, with SHAPEITv2[10] and imputed using Impute2[24] with reference panel samples
from the Sequencing Initiative Suomi (SISu Project)[36].
After all these steps a total number of roughly 28,000,000 SNPs were obtained.
2.4 Phenotypes
The study includes 23 different phenotypes:
• Low density lipoprotein (LDL) • High density lipoprotein (HDL)
• Triglycerides (TG) • Apolipoproteins AI, AII, B, and AI:AII
ratio
• HDL per Apolipoprotein AI ratio • HDL2 cholesterol per HDL3 cholesterol
ratio
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• Cholesterol ester transfer protein (CETP) • pre-beta HDL
• Phospholipid transfer protein activity,
and mass
• HDL size 1
• Hepatic lipase activity at 15 minutes after
administering heparin[25]
• Lipoprotein lipase activity at 15 minutes
after administering heparin
• HDL TG, and VLDL TG • HDL particle sizes 2a, 2b, 3a, 3b and 3c
21
Chapter 3
Methods
3.1 Linear mixed model
3.1.1 Introduction
A linear mixed model (LMM) is used when the data have clusters, repeated-measurements or
when the data are longitudinal[50]. The LMM is used to model the dependencies between the
observations. If LMM is not used when it is needed the chance of false results will be higher
because the type I or type II error rates increase. This will be shown via simulations later in
chapter 4.1.
In the case of the EUFAM data the individuals are from families which can be thought of
as clusters for the phenotypic data. Individuals from the same family are more likely to have
similar phenotypes as a result of shared genetics and shared environment.
We could also study dyslipidemias using a population sample. In that case a linear mixed
model might not be needed. However, the family data might contain information that is
not observable using population samples. The families used in the study are suffering from
dyslipidemias so there might be some kind of genetic component that makes the families more
susceptible to the disease. And because of the family structure we also gain a boost in the
power when using a linear mixed model.
Let us take a brief glance at the over one hundred year old history of linear mixed models.
The first step was taken by Airy in 1861 who was interested in observations of the nights sky.
He formulated the first linear model with random effects. Two years later Chauvenet calculated
the variances of the random effects in his astronomy related studies. Then, over sixty years later
in 1925 Fisher wrote a book containing a method for estimating variance components. This
method was extended to fit the linear model framework by Tippet in 1931. The division to fixed-
and random-effects models was done in 1947 by Eisenhart, who introduced the mixed model
terminology. The maximum likelihood (ML) methods for obtaining estimates for the linear
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mixed models were introduced by Hartley and Rao in 1967. The ML methods were biased
downwards and the unbiased restricted maximum likelihood (REML) methods were shown by
Patterson and Thompson in 1971. From mid 1970’s onward the LMMs were applied regularly
in agricultural studies and in 1990s they started to become popular in medicine.[50]
3.1.2 From linear model to linear mixed model
Linear model with only fixed effects
An example of a linear model with only fixed effects would be that we model the weight of a
person by comparing the effects of age to the weight. We can model this as follows:
yi = µ+ xiβ + εi
where yi refers to the individual’s weight, µ is the baseline weight, xi is the individual’s age,
β is the effect of the age on weight and εi an error term. The error terms are assumed to be
independently distributed random variables with εi ∼ N (0, σ2).
We assume that the effect of the explanatory variable ”age” is constant meaning that the
coefficient β is a fixed value. This is a so called fixed effect.
When using a fixed effect we assume that from the perspective of the study we have all the
interesting levels or conditions available. The levels of variable are selected in a way that they
represent specific conditions. They can also be used to define contrasts that are interesting.
For example we could create age groups and ask “how much does the age effect differ when
comparing younger and older individuals”.
Linear model with only random effects
Let us say we are interested in the effect of the family (shared environment, for example diet)
on the weight of the individual. The sampled families can be though of as clusters for the
individuals and we would use a random effects model as we would assume that each family has
some variation from the population mean. The formula for individual’s weight would now look
like this:
yi = µ+ gF (i) + εi,
where gF (i) refers to the random variable, the family effect for the individual. Here F (i) is the
family of the ith individual. The other terms are the same as in the previous example. The
random variable gF (i) has a distribution of N (0, σ2g) where σ2g refers to the variance caused by
the families. This is the most important difference between fixed effects and random effects:
fixed effects are constant and random effects come from a distribution.
In this example the random effects represent the difference in the weight caused by the
families to the average weight. The random effects here are random intercepts, they describe
the variance from the overall fixed intercept.
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When using a random variable we do not need to observe all the levels of the factor. We
can instead think of it being randomly sampled from the population of levels under the study.
So when using the random effects model we use our observed levels of the variable to make
interferences about all the levels of the variable.
Here we could also model the effects of the family to the weight of the individual using
fixed effects if we were more interested in the differences that the families that we have sampled
cause to weight rather than the deviations caused by families in general. The question we want
to answer affects the model we use!
We cannot use a fixed effects model unless the model captures all the dependence between
the individuals. For example, we might have families which are related to each other. When
using a fixed effects model we would not be able to take the relatedness of the families into
account. This causes the error terms to be dependent on each other and breaking the assump-
tions of the model. The random effects model can take the clustering into account even if it is
not as simple as with the example above about independent families.
LMM = fixed effects + random effects
A linear mixed effects model simply combines both the fixed effects model and random effects
model. Continuing with the example we could add both the age of the individual as well as
the shared family environment of the individual as the effects for the weight of the individual.
We are more interested in the effect of the age to the weight of the individual. So rather than
estimating the differences between the families we assume that families in general have an effect
and we estimate variance of that distribution. Hence we model families as random effect. Using
the earlier notation the model is:
yi = µ+ xiβ + gF (i) + εi.
where yi refers to individual i’s weight, µ is the baseline weight, xi is the age of the individual
i, β is the coefficient for the age, gF (i) is the random effect of the individual’s family, and εi is
the error term.
We can now clearly see where the name linear mixed effects model comes from. The model
combines both fixed and random effects.
Linear mixed models are needed when we know that there is some clustering in the data
that needs to be taken into account when estimating the fixed effects. Using a linear model
when clustering exists usually leads to inflated type I error, that is, we might find significant
association when there is none.
As in the previous section we could model the effect of the shared family environment as a
fixed effect if we are more interested in the differences of the sampled families on the weight of
the individual.
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Formulas using matrices
The above models can also be specified using matrices as follows
• Linear model with fixed effects
yn×1 = µn×1 + Xn×pβp×1 + εn×1
• Linear model with random effects
yn×1 = µn×1 + gn×1 + εn×1
• Linear mixed model
yn×1 = µn×1 + Xn×pβp×1 + gn×1 + εn×1
Where y is a vector of length n, the number of the individuals:
yn×1 =

y1
y2
...
yn
 .
The fixed effect vector β has the length of the number of the parameters in the model:
βp×1 =

β1
β2
...
βp
 .
The fixed effect matrix X is of size n × p, the number of individuals times the number of
parameters in the model:
Xn×p =

x1,1 x1,2 · · · x1,p
x2,1 x2,2 · · · x2,p
...
...
. . .
...
xn,1 xn,2 · · · xn,p
 .
The vector g is of length n of the individuals and g ∼ N (0,Dn×n). The covariance matrix
Dn×n can be used to specify the clustering of the individuals. A general form of the matrix is
Dn×n = Var(g) =

var(g1) cov(g1, g2) · · · cov(g1, gn)
cov(g1, g2) var(g2) · · · cov(g2, gn)
...
...
. . .
...
cov(g1, gn) cov(g2, gn) · · · var(gn)

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The D matrix is both symmetric and positive-semidefinite[50].
The last term, ε, is a vector of the error terms
εn×1 =

ε1
ε2
...
εn

and it follows a multivariate normal distribution with zero mean and σ2In as the covariance
matrix. Here In refers to the identity matrix of size n× n.
Restricted Maximum Likelihood
REML gives unbiased estimates of the variance components. To illustrate, if we use maximum
likelihood criterion to a sample of N observations from a univariate normal distribution Y ∼
N (µ, σ2) the estimator we acquire for σ2 is
σ̂2ML =
1
N
N∑
i=1
(Yi − Y¯ )2, where Y¯ = 1
N
N∑
i=1
Yi
which underestimates σ2. This can be seen since
E(σ̂2ML) =
n− 1
n
σ2
The unbiased estimated for σ2 is
σ̂2REML =
1
N − 1
N∑
i=1
(Yi − Y¯ )2
where the subtraction of 1 in (N − 1) comes from the fact that one degree of freedom is
used in calculation of Y¯ to estimate E(Y).
Similarly, we can obtain an REML estimator for multivariate normal distribution (MVN).
We use a likelihood which does not contain information about the fixed effects parameters but
has all the information about the variance components[14].
Let us assume we have a variable Y which follows distribution MVN(Xβ,V) and that the
design matrix X is of full rank r, the total degrees of freedom of the fixed effects. Let K be a
(N − r,N) full rank matrix:
K =

kT1
kT2
...
kTN−r
 ,
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that satisfies KX = 0.
It follows that
E(KY) = KXβ = 0β = 0
and
V ar(KY) = KV ar(Y)KT = KVKT .
Thus
KY ∼MVN(0,KVKT).
Now we can use the maximum likelihood approach on this distribution to obtain a restricted
maximum likelihood estimator for the variance components. The likelihood is missing the fixed
effects and contains r fewer observations than the likelihood of the original observation vector
Y[14].
Expectation-Maximization
The EM algorithm is an iterative way of finding a maximum likelihood estimate or the posterior
mode of the original model. We can use it with incomplete data to estimate parameter.[11]
The summarized version of the EM algorithm is that we first choose some initial values for
the parameters we want to estimate. Then the algorithm will alternate between the E-step and
M-step until a convergence criteria is fulfilled. In the E-step we use the current parameters to try
to find the probability distribution, or rather expected sufficient statistic, over the completions
missing data. At the M-step we use the previously obtained expected sufficient statistics to
estimate the parameters again. It is called the M-step because we ’maximize’ the expected
likelihood of the data.[13]
3.2 The model used in this thesis
A linear mixed effects model was used for both the heritability estimation and association
testing. The need for LMM comes from the shared genetics and shared environment between
the individuals which causes the individuals to be clustered in groups.
Two nested LMMs were used in this thesis: one with only the additive genetic effect as
a random effect and another model with an additional family component, the common fridge
effect, as a random effect. The common fridge effect refers to the effect of shared family
environment: the family shares the living habits among its members, including what they eat
(i.e. they have a common fridge). As the models are nested they can be compared using a
likelihood ratio test but the standard asymptotic results do not hold when testing whether to
keep the variance component or not. We will look at this in more detail at chapter 3.4.5.
The full formulas for the models are the following:
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• the model with only the additive genetic effects, M1,
y = µ+ Xβ + g + ε (3.1)
• the model with both the additive genetic effects and the common fridge effect, M2,
y = µ+ Xβ + g + f + ε (3.2)
where y is the phenotype and β is the coefficient for the fixed effects X, that include only
the SNP to be tested, as age and sex effects have been regressed out using a linear model
before the GWAS or the heritability testing. The random effects included in the model are the
genetic effect g and the family effect f . The error term ε can be thought of as the effect of the
environment: the effect of everything besides the additive genetic effects and common fridge
effects. We assume that g follows the distribution N (0, σ2gR), where R is the relatedness matrix
and σ2g is the additive genetic variance. Similarly, we assume that f comes from N (0, σ2fF)
distribution. Here F is the shared family environment matrix and σ2f shared family environment
variance. The last term, ε, is the environmental variance which follows distribution ofN (0, σ2eI),
where I is identity matrix and σ2 is the environmental variance.
The heritabilities were estimated using GCTA[53] using both of the models. GCTA uses
expectation-maximization based algorithm in REML.
The GWAS was only done with the simpler model as the MMM [40] software does not
support multiple random effects. MMM uses maximum-likelihood estimation.
3.2.1 Relatedness matrix
Relatedness matrix R describes how individuals are genetically related to each other. A rule
of thumb for the values is that the individual has a relatedness value 1 with themselves, 0.5
with their parents and full siblings, and 0.25 with their half siblings. These values are the
expectations of the relatedness values calculated from the pedigree structure.
I calculated the relatedness matrix using the SNP data and the MMM software[40]. The
formula used for calculating the relatedness for individuals i and j is
Rij =
1
Mij
∑
l∈Mij
(zli − 2pˆl)(zlj − 2pˆl)
2pˆl(1− pˆl) (3.3)
where Mij is the set of loci l without missing data for i and j individuals. The matrix z contains
loci as rows and individuals as columns. Alleles in the loci are coded with 0, 1 or 2. The term
zli is the genotype of the ith individual of locus l. The frequency of the locus l’s allele 1 pˆl, is
estimated from the data.
SNPs with SNP info < 0.8 or minor allele frequency (MAF) < 0.01 were dropped when
estimating the genetic relatedness between the individuals.
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3.2.2 Family matrix
The shared family environment matrix F for the family effect, or common fridge effect, f ∼
N (0,Fσ2f ) is the following:
Fij =
{
1 if individuals i and j are from the same family,
0 otherwise.
(3.4)
Here we assume that the shared family environment is the same for the whole family.
The covariance matrix could be formulated more accurately if the shared family environment
was more precisely measured. For example, the shared family environment probably has a
greater effect when the individuals have lived together for 20 years than when the individuals
have just moved together. But even with more precise measurements we would also need a
way to formulate the information numerically. And as we are more interested in the additive
genetic effects in this study the assumption of the “common fridge” for the whole family is
enough to at least take some of the shared family environment variance out from the additive
genetic effects.
3.2.3 Heritability
Depending on the model the formulation for the narrow-sense heritability is
h2 =
σ2g
σ2e + σ
2
g
(3.5)
for the simpler model M1 (3.1) and
h2 =
σ2g
σ2e + σ
2
g + σ
2
f
for the model with both genetic component and the common fridge effect M2 (3.2).
The model with the shared family environment effects might give heritability estimates
closer to the true values. The additive genetic effects estimated with the model M1 could also
contain some of the variance caused by the shared environment, leading to biased heritability
estimates. The potential upward bias caused by the shared environment has been reported in
twin studies[54].
3.3 LMMs in previous studies
Linear mixed models were not used much for the first few years of GWAS because of computa-
tional issues[55]. Now these issues have been solved and there are even papers comparing the
different software implementing the LMMs[17].
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Linear mixed models have been used previously with family-based data. For example,
a study found genetic variants that affect plasma plasminogen levels (PLG) and estimated
heritability for the PLG using a cohort of sibling pairs[28]. LMMs have also been used in
testing association in many studies ranging from human intelligence[8] to bread wheat[31].
Yang et al. go through the advantages and drawbacks in their article “Advantages and pit-
falls in the application of mixed-model association methods”(2014) [51]. They prove that when
used to test association linear mixed models prevent false positives because of the population
or relatedness structure and increases the power when correcting for this structure. They argue
that when calculating the genetic relationship matrix used in the model the candidate marker,
the SNP that is tested for association, should be excluded to avoid double fitting it into the
model. In this thesis this instruction has been followed.
The linear mixed models can also be used for studies using population samples[22]. When
using a population sample there needs to be a correction for population stratification. There are
different methods to take the population structure into account. For instance, genomic control
adjusts the test statistics for it. The population structure can also be taken into account
using principal component analysis (PCA): the principal components produced by PCA can be
added to the linear model as covariates to explain the population stratification. However, the
relatedness matrix used in the linear mixed model captures both population structure and the
relatedness of the individuals while genomic control and PCA only capture the former[22].
3.4 Statistical testing
3.4.1 Introduction
When we perform statistical tests we formulate a null hypothesis and an alternative hypothesis.
For example, we could study if some SNP had an effect on HDL. In this case the null hypothesis
would be that the SNP has no effect on the HDL, i.e. H0 : β = 0. Here β is a coefficient for
SNP effect on the HDL levels. An alternative hypothesis would be that the SNP has an effect
on the HDL levels, H1 : β 6= 0. When comparing these hypotheses we either reject the null
hypothesis and accept the alternative hypothesis or we do not reject the null hypothesis.
P-value is the probability of obtaining the observed or more extreme results when the null
hypothesis is true. We reject the null hypothesis if the p-value is small enough that obtaining
the results would be extremely unlikely under the null hypothesis.
When performing a statistical test we first select a threshold, e.g. the genome-wide signif-
icance threshold, and then calculate the p-value and compare it to the threshold. If we have
a p-value equal to or lower than the threshold we reject the null hypothesis and accept the
alternative hypothesis. If the p-value is larger than the threshold we do not reject the null
hypothesis. The threshold is called significance level and if we obtain a p-value that is equal
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Type I errorType II error
Null hypothesis
H0
Alternative hypothesis
H1
Type I vs. Type II error rates
Figure 3.1: Illustrating the dependence between type I and type II errors. Here the red vertical
line represents the cut-off for rejecting the null hypothesis.If we increase the significance level
to lower the risk for performing type I error we consequently increase the chance for type II
error occurring.
to or lower than it we obtain a statistically significant result.
3.4.2 Type I error
Type I error means an incorrect rejection of the null hypothesis. In the case of SNP data it
means we incorrectly find an association between a SNP and a phenotype. The type I error rate
usually is the same as the significance level of a test and is often denoted by the Greek letter α.
If we set the significance level to, say, 5% then it would mean that the conditional probability
of type I error when the null hypothesis is true is 5%. Thus if we run a large number of tests,
then around 5% of the true null SNPs would be wrongly assigned to be significant.
3.4.3 Type II error and power
Type II error occurs when the null hypothesis is false but it is not rejected. This would mean
that even though a SNP has a nonzero effect on the phenotype we fail to notice it as such using
the statistical test. The rate of type II error is denoted by γ.
The power of a statistical test is the probability of not committing a Type II error. In other
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words, it is the probability of the test to reject the null hypothesis when the null hypothesis is
false. Thus power is 1− γ.
The amount of power a statistical test has depends on the characteristics of the data, the
size of the effect we wish to observe, the sample size of the data and the significance level
chosen. The dependence between performing a type I error and type II error is illustrated in
Figure 3.1. This means that with a small sample size the test might have enough power to
detect SNPs with larger effect sizes but SNPs with smaller effect size are harder to detect.
3.4.4 Testing association
Association testing means we test whether a SNP is associated with the phenotype. A simple
example would be testing if a SNP with alleles A and T has an effect on phenotype. If we are
testing the effect of the T allele the allele pairs are usually coded with AA = 0, AT = 1 and
TT = 2. This indicates that the effect of the tested allele is assumed to be additive. Here the
hypotheses are H0 : β = 0 and H1 : β 6= 0.
Likelihood-ratio tests (LRTs) can be performed to check whether the SNP has a significant
effect. This is done by comparing two models, the model with the SNP (“alternative model”):
y = µ+ Xβ + g + ε
09 and the model without the SNP (“null model”):
y = µ+ g + ε,
here µ refers to the intercept term.
The likelihood-ratio test compares the likelihood of the null model to the alternative model.
The null model of LRT should be a special case of the alternative hypothesis. The test statistic
is:
Λ = −2 log
(
likelihood for the null model
likelihood for alternative model
)
= −2 log(likelihood for null model) + 2 log(likelihood for alternative model)
where the likelihoods are maximized. In large samples the test statistic approximately follows
χ2df2−df1-distribution when the null hypothesis is true. The degrees of freedom is equal to the
differences in numbers of parameter in the null model (df1) and the alternative model (df2).
The degrees of freedom here is one since only one SNP was tested. We reject the null hypothesis
of the null model of β = 0 with large test statistics. This happens when the likelihood of the
alternative model is large enough to justify the extra parameter(s).
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3.4.5 Variance components
Models with different variance components cannot be compared using LRT with χ2 test statistic
distribution as the null hypothesis is on the boundary of the parameter space. This happens,
for example, if we test whether the additive genetic effects should be included in the model by
comparing the null hypothesis of σ2g = 0 to the alternative hypothesis σ
2
g > 0.
If we assume that the data are independent identically distributed (IID) the likelihood ratio
test statistic of a variance parameter has asymptotically distribution 0.5χ2q + 0.5χ
2
q+1, where q
is the number of constrained fixed effect parameters under the null hypothesis[45]. The IID
assumption does not usually hold for LMMs and it has been shown that with null hypothesis
q = 0 the asymptotic approximations of the mixture distribution 0.5χ2q + 0.5χ
2
q+1 should be
used with caution[5]. Despite of this, GCTA uses the mixture distribution δ0 + 0.5χ
2
1, where δ0
is the point mass at zero.
3.4.6 Wilcoxon rank-sum test
The Wilcoxon rank-sum test (also known as Mann–Whitney U test) is a nonparametric test
that compares the location parameters of two independent populations. It is comparable to a
two-sample t-test but unlike the t-test, the Wilcoxon rank-sum test does not assume that the
data are normally distributed. The test is based on the ranks of the data.[49]
Let’s assume we have data of two independent groups x and y where x has nx samples and
y has ny samples. Let rxi be the rank of xi and ryi be the rank of yi among the combined data
set {x,y}. Now we can obtain the rank sums:
Rx =
nx∑
i=1
rxi
and
Ry =
ny∑
i=1
ryi.
The null hypothesis of equal location parameters can be tested by comparing the rank sums
of the two groups. If the null hypothesis is true, then Rx/nx should be close to Ry/ny. An exact
probability can be used to determine a rejection region for this statistic with smaller samples.
For larger samples a normal approximation can be used. With N = nx + ny samples under H0
we would expect nx/N samples be from group x and ny/N samples be from group y. Therefore
the expected value of Rx under H0 is:
E(Rx) =
(nx
N
)(N(N + 1)
2
)
=
nx(N + 1)
2
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where
(
N(N+1)
2
)
is the sum of all the ranks. The variance of Rx can be calculated with
var(Rx) =
nxny
12
(N + 1).
If there are tied data values the formula for the variance changes slightly. The average rank
of the tied values are assigned to the corresponding rji values. If there are g groups of tied
data values then for the ith group we compute ci = m(m
2 − 1) where m is the number of tied
values for that group. We use these to make small correction factor, C = c1 + c2 + · · ·+ cg, to
the variance[49]:
σ2Rx =
nxny
12
(
N + 1− C
N(N − 1)
)
.
Now we can obtain the test statistic for the null hypothesis that the mean, median or other
location parameters for the two populations are equal. The test statistic is:
Z =
Rx − E(Rx)√
var(Rx)
. (3.6)
The test statistic is approximately normally distributed and large values of |Z| lead to the
rejection of H0.[49]
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Chapter 4
Results
4.1 Simulations
4.1.1 Introduction
I did the simulations to prove that the statistical model used in the thesis works. The accuracy
of the heritability estimates was checked first. This was followed by testing the performance
of the linear mixed model in association testing and also comparing it to the standard linear
model. The R software[41] and package mvtnorm[19] were used to generate the simulation
data.
The simulations were done using the pedigree structure from the EUFAM data. The inheri-
tance of a SNP was simulated by giving alleles to the founder members1 of a pedigree and then
simulating inheritance for the rest of the pedigree members. The offspring inherits one allele
from each parent and the allele is randomly chosen with 50% probability from the allele pair
the parent has. An example of a SNP simulation for a pedigree can be seen in Figure 4.1.
The polygenic effect vector was generated from multivariate normal distribution with a
vector of zeros as the mean and Rσ2g as the covariance matrix as defined in 3.2.1. The family
effect vector f was generated similarly, but with Fσ2f as the covariance matrix. The error term
was generated from normal distribution; again with zero mean and variance 1− σ2g − σ2f − σ2s ,
so that total variance is 1. Here σ2s refers to the variance due to the simulated SNP’s.
4.1.2 SNP effect
The phenotypic variance of a SNP can be calculated using the following formula:
σ2s = β
22f(1− f) = 1− σ2 (4.1)
1individuals who do not inherit from anyone in the pedigree
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Figure 4.1: An example SNP simulation for a pedigree structure from the EUFAM data.
“Founders” are members who do not inherit SNPs from anyone else in the pedigree. Here
we simulate two alleles A and T for the founders from Bernoulli distribution and then simulate
the inheritance of the alleles.
where β refers to the allelic effect of the SNP, f is the allele frequency and σ2 is the variance
from other sources such as shared genetics and environment.
By solving the above equation for SNP effect we get:
β =
√
1− σ2
2f(1− f) , (4.2)
This equation can be used when simulating SNPs for the model testing or when calculating
the power of the statistical test.
4.1.3 Accuracy of the heritability estimates
I used GCTA[53] to estimate the heritabilities. The estimates for different variances were tested
by checking how close the estimates from the simulations were to the true values the simulations
were done with. All the simulations were done using 1000 simulation samples.
The simulations were done using two models. A simpler model, M1, only includes the
additive genetic effects:
y = µ+ Xβ + g + ε.
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Table 4.1: Number of successful runs with GCTA in each simulation category. There was a
drop of successful simulations with the model including both the additive genetic effects and the
common fridge effect (M2) when the lead variance component caused almost all the variation in
the model. The most extreme case was when the family component causes 99% the variation:
none of the runs were successful.
GCTA number of simulations
Lead variance component
Model M1 Model M2
Variances σ2g σ
2
g σ
2
f σ
2
e
0.01 1000 1000 1000 1000
0.10 1000 1000 1000 1000
0.25 1000 1000 1000 1000
0.50 1000 1000 1000 1000
0.75 1000 1000 1000 1000
0.90 1000 992 964 996
0.99 1000 803 0 909
The other model, M2, includes both the additive genetic effects and the common fridge effect:
y = µ+ Xβ + g + f + ε.
When checking the performance of the common fridge model one variance component was
given a specific value and the two others were half of the remaining variance. The same routine
was done for all the variance components. The results for model M1 can be seen in Figure 4.2
and for model M2 in Figure 4.3.
GCTA had some problems estimating the variances when one variance component caused
almost all the variance in the full model. The variance estimates did not converge so the results
were dropped. The number of successful runs in each simulation category can be seen in Table
4.1 The most drastic problem occurred when the family component caused 99% of the total
variance: none of the estimates were proper. There were no problems with the estimates when
using the simpler two variance component model M1.
4.1.4 Association test simulations
I used the program MMM[40] for association testing. As the program does not support two
random effects the testing was done using the model without the common fridge effects. So the
comparisons were done between the model with additive genetic effects, M1,
y = µ+ Xβ + g + ε
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Figure 4.2: The simulation results for the model without the common fridge effect. GCTA had
problems when the variance of the genetic component was close to one, some of the simulation
results were dropped out. Overall the GCTA seems to be accurate for model M1.
and a standard linear model (M0), that is, a model without the additive genetic effects:
y = µ+ Xβ + ε.
Type I error
I did the Type I error testing by changing the SNP vector (fixed effects of the model) to another
simulated SNP vector (Z) in the linear mixed effects models when estimating β. The model
used for this was:
y = µ+ Zβ + g + ε, (4.3)
where y is the phenotype vector, Z is the switched SNP vector, β is the coefficient, g is the
genetic effect vector, and ε is the environmental effect.
I studied the effect of the type I error of the likelihood-ratio tests at different p-value. The
simulations were done using a sample of 1 000 individuals from the EUFAM data. The largest
pedigrees were included until over 1 000 individuals were acquired. Then random participants
were dropped from the smallest family included until the exact sample size was acquired. The
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Figure 4.3: Testing GCTA with the model with the common fridge effect. The estimates were
accurate even with three variance components. Although GCTA again had problems when the
variance of a component was close to one. This was most notable with the family environment
component where all the results for the 99% variance simulations were discarded.
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results of type I error simulations for 1 000 runs can be seen in the table 4.2. It would seem
that the standard linear model had inflated p-values when compared to the linear mixed model.
Significance level α M1 M0
0.10 0.113 0.134
0.05 0.058 0.087
0.01 0.009 0.030
Table 4.2: Table of Type-1 errors. The type-1 errors were slightly inflated when the standard
linear model (M0) was used.
Type II error and power
I did the power testing for the linear mixed model (M1) using simulation approach; the per-
centage of tests where the null hypothesis is discarded is an estimate of the power of the test.
The simulations used the EUFAM family pedigrees similarly as in the type I error checking:
largest pedigrees were chosen until the desired sample size was acquired. If the sample size was
more than needed individuals were randomly dropped from the smallest included family. For
both the sample size and SNP variance power simulations 1 000 simulations were done.
I calculated the power of the standard linear model (M0) analytically for an unrelated
population sample. Under the null model the test statistics were assumed to come from a χ2
distribution. This was compared to the values we would get under the alternative hypothesis
where the test statistic follows a χ2(λs) distribution where λs = 2nf(1 − f)β2 is the non-
centrality parameter.
When increasing the sample size the power of both the linear mixed model and linear model
seem to be around the same as seen in the top graph in Figure 4.4. There did not seem to
be a lot of difference in power between the models. This might be caused by only doing 1000
simulations and the small sample size. But the linear mixed model seems to perform at least as
well as a standard linear model with a population sample would perform in similar conditions.
Here σ2g = 0.50 and the SNP explained 1% of the variance.
I also did simulations to check the power depending on how much variance the SNP explains
in the model. These simulations were done using sample size of 1 000 individuals and σ2g was
fixed to 0.50. The results were similar to the sample size power simulations: there was not
much difference between the two models. The lower graph of Figure 4.4 illustrates this.
I compared the SNP effect and standard error estimates to further investigate power differ-
ences between LMM and standard linear model. First, I re-did the simulations using a model
without any heritability, Mh2=0 (i.e. σ
2
g = 0). Then, I compared the standard linear model
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Figure 4.4: Power simulations for sample size and the percentage of variance explained by the
SNP. The linear model power was calculated analytically. The power levels did not differ much
between the linear mixed model and the standard linear model. In the upper panel power was
calculated for different sample sizes assuming that the SNP explains 1% of the variance. In the
lower panel the power was calculated by changing the variance that the SNP explains with a
sample size of 1000 individuals. A power level of 80% is commonly sought for studies and is
highlighted with the horizontal dots on both of graphs.
41
estimates for the SNP effect size and standard error from model Mh2=0 to LMM estimates on
data that was simulated with σ2g , Mh2=0.5.
I tested the pairwise differences between the two models across all the different simulation
parameter sets with Wilcoxon rank-sum tests. After applying Bonferroni corrections none of the
SNP effect size estimates were different between the two models Mh2=0 and Mh2=0.5. However,
all the standard error distributions had a significantly lower location parameter with model
Mh2=0.5. Thus, the linear mixed model has more power than the standard linear model when
additive genetic effects exist. Figure 4.5 shows an example boxplot of SNP effect and standard
error estimates between the two simulation models with sample size of 1,000.
Figure 4.5: Boxplot comparing the SNP effect and standard error with additive genetic effects
and without additive genetic effects, the former done with LMM and the latter done with
a standard linear model. The LMM was more precise than the standard linear model when
heritability was greater than zero. This example is from the simulations with 1,000 samples
and 1% of the variance being explained by the SNP.
4.1.5 Summary of the simulation results
The heritability estimates were accurate for both of the models M1 and M2. However, the
estimates lost accuracy when a single variance component caused almost all the variance in the
model with two variance components (M2). Some of the simulations were discarded when a
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single variance component caused almost all the variance in model M2 as GCTA did not reach
convergence.
It seemed that there was not much difference in the power between the linear mixed model
and the standard linear model based on the power plots. However, comparison of the standard
errors revealed that the LMM was more precise than standard linear model when heritability
existed in the data. The standard linear model also had inflated type I error values as it did
not take the relatedness of the individuals into account. Based on these results the linear mixed
model M1 seems to be a better choice for these data than the standard linear model M0.
4.2 EUFAM data
I estimated the relatedness matrices from the genotype data using the MMM-software[40]. The
matrices were estimated chromosome by chromosome and then combined to create matrices
specific for each chromosome for association testing to avoid “double fitting” a SNP in the
model. A matrix with all the chromosomes combined was done for estimating the heritability.
Before the analyses the phenotypes were quantile normalized. In quantile normalization the
phenotype values are ranked and then same number of points from the target distribution, a
standard normal distribution, are ranked. We then give the same ranked points in the phenotype
distribution values from the standard normal distribution. Thus the phenotypes will have a
standard normal distribution. The phenotypes were also adjusted for both age and sex.
4.2.1 Heritability
I estimated the heritability using GCTA[53] where the linear mixed model approach outlined
in the earlier chapters was used. The heritabilities were also estimated using SOLAR[1], which
uses a family structure based approach. The SOLAR estimations were done by Susan Service at
the University of California at Los Angeles. The results from the two different approaches can be
seen in Figure 4.6. Apart from a few phenotypes, the estimates were very similar. Furthermore
the phenotypes with over 10% difference were estimated with less than 200 individuals, which
may explain the larger differences between the estimates.
I also estimated the heritabilities with the model that includes the shared family environ-
ment. The comparison between the models with and without the common fridge effects (models
M2 and M1) are in Figure 4.6. The heritabilities were smaller than when using the model with
the common fridge effects. The common fridge effect “absorbed” some variance from both the
heritability and the environmental effects. The additive genetic effects might actually contain
some of the variance caused by the shared family environment. So the heritability estimates
obtained with the model M2 might be closer to the true values. The results were discarded for
two phenotypes with < 200 samples as the estimates did not converge.
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I compared the model with both additive genetic effects and common fridge effects (M2)
to the model with only additive genetic effects (M1) using LRT where the test statistic was
assumed to follow mixture of 0 and 0.5χ21 distribution. In the estimates with more than 200
individuals the null hypothesis of σ2f = 0 was rejected in 11 phenotypes with the significance
level of 5%. The H0 was strongly rejected (p-value < 10
−3) in five phenotypes with n > 200.
According to the LRT the family component seems to be a justifiable addition to the model
when estimating heritabilities. But as mentioned previously in chapter 3.4.5 one should use
these p-values with caution.
The traits were fairly heritable: according to GCTA the narrow-sense heritability of most of
the phenotypes was between 30% to 50% with the model that includes common fridge effects.
From the perspective of the EUFAM study this was good news. It would be disappointing if
the phenotypes were not heritable. This would imply that we would not be able to learn much
by doing the GWAS as phenotype variation would come from other sources rather than from
the additive effects of the SNPs.
4.2.2 GWAS
I did the GWAS using the model without the common fridge effects, that is model M1, with
the MMM[40] software.
As mentioned previously I did the association testing using the relatedness matrix without
the chromosome whose SNPs were tested because this prevents “double fitting” the SNP that
was tested[51]. As part of quality control, SNPs with minor allele frequency ≤ 0.01, SNP info
≤ 0.8, or sample size less than 200 were dropped.
Results for the GWAS for both the linear mixed model M1 and the standard linear model
M0 can be seen in Figure 4.7. When using the linear mixed model ten loci, regions with the
length of 2-mega-base-pairs with the SNP with the lowest p-value as the center, with genome-
wide significant associations were found, with the locus in chromosome 15 having a very strong
signal. When a normal linear model was used for testing the associations a severe inflation of
type I error was present. This was caused by the pedigree structure present in the data not
being taken into account.
Most of the loci found were previously associated with the same trait or similar traits which
gave us further confidence that the results were true.
QQ-plot for hepatic lipase activity in chromosome 16 can be seen for both the linear mixed
model (M1) and the standard linear model (M0) in Figure 4.8. In a QQ-plot we compare the
test statistic’s expected values to the observed ones. If the associations are true then the QQ-
plot points would follow the diagonal line and only be more than the expected values at the
far right. And if the observations are more than what we would expect through out the scatter
plot the amount of type I error would be inflated. With the standard linear model the values
for the test statistic were inflated for many of the observations leading to inflated amount of
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Figure 4.6: A comparison between the estimated heritabilities when using GCTA and SOLAR,
and when using the model with common fridge effects (M2) and without common fridge effects
(M1). All the estimated heritabilities with over 10% difference to the SOLAR’s estimates
had a sample size smaller than 200. The common fridge model heritability estimates were
always smaller to the ones made without the family environment component. Apart from one
phenotype the most drastic differences once again occurred with phenotypes having a small
sample size.
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Figure 4.7: Manhattan plots of both models for all the phenotypes. Inflated p-values were
obtained with the standard linear model. In both graphs the −log10(p-value) ware restricted to
be maximum of 16. The dashed line indicates the genome-wide significance of −log10(5×108) ≈
7.3. True associations are more likely when there are other associations detected in the same
region of the genome, that is, there is a pillar of associations instead of a single dot.
type I error in the testing. The linear mixed models observed values were nearly all what we
would expect. Therefore a false positive for 5× 10−8 of the tests was obtained. There was also
a numerical measurement for the fit of the model called the genomic inflation factor [12][9]:
λ =
median of observed
median of expected
.
The ratio of the medians measures how the observed and expected values match thus assessing
the model fit and false positive rate. In this example the linear model had a λ greater than one
indicating a poor fit of the model for the data and inflated false positive rate. If λ is nearly one
the observed values are what we would expect with the model. The LMM had a λ of nearly
one indicating a good fit.
4.2.3 Summary of the EUFAM results
The heritability estimations showed that the phenotypes were indeed influenced by additive
genetic effects, in most cases the effect was between 40% to 50% with the model without the
common fridge effects(M1). The model with the common fridge effects(M2) estimated the
heritabilities to be around 30% to 40%. The high heritabilities mean that we could find those
effects with a GWAS more easily. When comparing the two models, the LRT favoured the
model with both variance components.
The GWAS done on the EUFAM data revealed ten loci that associated with the phenotypes
related to metabolomites. Several of the loci were previously associated with the same traits
or traits similar to those studied in the EUFAM project. The results will be published later.
47
Figure 4.8: The QQ-plots for both the linear mixed model’s and standard linear model’s test
statistic for hepatic lipase activity at chromosome 16. The red dashed lines are 95% confidence
interval for independent observations. Most of the observation are in the lower left corner as
shown in the density plots below the QQ-plots. With the linear model the test statistics were
greater than what we expect for quite a few observations throughout the scatter plot. This
highlights the inflated type I error observed with the standard linear model. With linear mixed
model nearly all of the observed test statistics are what we would expect with this sample size.
The associations we might detect are in this case most likely results of type I error but the
amount of type I errors is not inflated unlike with linear model. Here λ, a ratio of the medians
between the observed values and expected values, measures the overall fit of the model and
values that differ from one imply a poor fit. Based on λ the LMM seemed to fit well to the
data while the standard linear model did not fit well.
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Chapter 5
Conclusions
The aims of this Master’s thesis were to explain what linear mixed models are and why they
are needed and to test some available implementations using both simulations and real data.
The genetic background and the definitions for both heritability and GWAS were introduced
in the first chapter. The benefits of Finland in a genetic study was also illustrated.
In chapter 2 we looked at the EUFAM data: the collection of the subjects and both geno-
typing and imputing the SNPS. The phenotypes used in the analyses were also listed here.
The linear mixed model was introduced in chapter 3. We first looked at the linear model
with fixed effects and then with random effects. The most important difference between these
models was that with fixed effects we assume the coefficient we estimate to be fixed while with
random effects we assume it has a distribution, such as g ∼ N (0,Rσ2g) for an additive genetic
effect. The linear mixed model is a combination of these two type of linear models: it contains
both fixed effects and random effects. The model was then formulated for the EUFAM study.
Previous genetic studies done using LMMs were also examined in this chapter. The methods
chapter ended with presentation of statistical testing methods and terminology.
The results chapter 4 was divided into two sections: results for simulations and results for
the EUFAM data. The simulations were first looked at in chapter 4.1 to show that the standard
linear model was not enough when the data contain clustering between the subjects. When
comparing the standard linear model to linear mixed model there was inflation of type I error.
The LMM had roughly the same power with a family based sample as a standard linear model
with a population sample. When comparing the standard errors of the SNP effects between the
two models, the estimates from LMM were more precise when additive genetic effects existed.
Heritability estimation was also studied and GCTA gave accurate estimates for the variance
components. Few runs were discarded when the variance came almost completely from one
component but with real data this should not be an issue.
Some results for the EUFAM data were shown in the next chapter 4.2. The heritability
estimates were similar when using a family structure based approach without genetic data.
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This provides further proof that the model was working correctly. The heritabilities estimated
with both the additive genetic effects and the common fridge effects were smaller than those
estimated with only additive genetic effects. This could be a result of the additive genetic
effects explaining some of the variance caused by the shared environment in the model when
only one random effect was included. As a result the estimates from the model with both of
the random effects could estimate the heritability closer to the true narrow-sense heritability.
In the GWAS the standard linear model produced massive amount of false positives when
compared to the LMM (Figure 4.7). This demonstrates that for clustered data a linear mixed
model fits better than a standard linear model as the latter fails to take the clustering into
account.
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Acronyms
CHD Coronary heart disease.
DNA Deoxyribonucleic acid.
EM Expectation-maximization.
EUFAM European Multicenter Study on Familial Dyslipidemias in Patients with Premature
Coronary Heart Disease.
FCHL Familial combined hyperlipidemia.
FIMM Institute for Molecular Medicine Finland.
GWAS Genome-wide association study.
HDL-C High-density lipoprotein cholesterol.
LDL Low-density lipoprotein.
LMM Linear mixed model.
LRT Likelihood-ratio test.
MAF Minor allele frequency.
MI Myocardial infarction.
REML Restricted maximum likelihood.
SNP Single-nucleotide polymorphism.
TC Total cholesterol.
TG Triglycerides.
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